NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,255,587 | -7.9% | 141,370 | +1.3% | 0.01% | -12.5% |
| Q2 2023 | $6,792,108 | +102779.6% | 139,583 | +17.4% | 0.01% | 0.0% |
| Q1 2023 | $6,602 | +53.5% | 118,913 | +11.1% | 0.01% | +33.3% |
| Q4 2022 | $4,300 | -99.9% | 107,046 | +10.7% | 0.01% | 0.0% |
| Q3 2022 | $4,236,000 | +35.3% | 96,671 | +9.5% | 0.01% | +20.0% |
| Q2 2022 | $3,130,000 | -3.4% | 88,314 | +10.9% | 0.01% | +25.0% |
| Q1 2022 | $3,240,000 | -59.8% | 79,656 | -7.8% | 0.00% | -60.0% |
| Q4 2021 | $8,066,000 | -12.6% | 86,371 | +4.3% | 0.01% | -16.7% |
| Q3 2021 | $9,231,000 | +2.9% | 82,834 | +4.8% | 0.01% | 0.0% |
| Q2 2021 | $8,969,000 | -4.0% | 79,005 | -14.2% | 0.01% | -7.7% |
| Q1 2021 | $9,345,000 | -6.5% | 92,033 | -8.4% | 0.01% | -7.1% |
| Q4 2020 | $9,999,000 | +48.7% | 100,472 | +8.0% | 0.01% | +27.3% |
| Q3 2020 | $6,723,000 | +19.1% | 93,062 | -17.8% | 0.01% | +22.2% |
| Q2 2020 | $5,643,000 | +108.7% | 113,176 | +25.0% | 0.01% | +50.0% |
| Q1 2020 | $2,704,000 | -8.3% | 90,571 | +3.5% | 0.01% | +20.0% |
| Q4 2019 | $2,949,000 | +16.8% | 87,545 | +13.7% | 0.01% | 0.0% |
| Q3 2019 | $2,525,000 | +22.4% | 76,967 | +2.9% | 0.01% | +25.0% |
| Q2 2019 | $2,063,000 | +128.5% | 74,808 | +70.8% | 0.00% | +100.0% |
| Q1 2019 | $903,000 | +46.6% | 43,808 | -0.6% | 0.00% | +100.0% |
| Q4 2018 | $616,000 | -10.9% | 44,091 | +52.7% | 0.00% | 0.0% |
| Q3 2018 | $691,000 | +25.0% | 28,871 | -1.7% | 0.00% | 0.0% |
| Q2 2018 | $553,000 | +104.1% | 29,358 | +0.6% | 0.00% | 0.0% |
| Q1 2018 | $271,000 | +2.7% | 29,184 | -0.7% | 0.00% | 0.0% |
| Q4 2017 | $264,000 | -41.3% | 29,379 | -15.9% | 0.00% | 0.0% |
| Q3 2017 | $450,000 | +20.0% | 34,928 | +1.1% | 0.00% | 0.0% |
| Q2 2017 | $375,000 | +50.6% | 34,533 | +23.0% | 0.00% | 0.0% |
| Q1 2017 | $249,000 | -22.2% | 28,068 | +2.8% | 0.00% | 0.0% |
| Q4 2016 | $320,000 | +29.0% | 27,303 | +22.3% | 0.00% | 0.0% |
| Q3 2016 | $248,000 | -5.3% | 22,326 | +2.8% | 0.00% | 0.0% |
| Q2 2016 | $262,000 | – | 21,716 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
| Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
| Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
| Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
| Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
| Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
| Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
| Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
| Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
| BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |